Emergent BioSolutions
Focus: Emergent BioSolutions is a CDMO and specialty pharma company headquartered in Winnipeg, focused on biologics contract manufacturing and biodefense products across infectious diseases, vaccines, oncology, and immunology.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Emergent BioSolutions
AI assessmentNot HiringNo open roles listed right now. Follow Emergent BioSolutions to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$107M Part DDeclining
LOE Approaching
Flagship product generating 100% of company revenue but facing imminent loss of exclusivity, creating urgent need for pipeline replacement.
Help build intelligence for Emergent BioSolutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.